Involvement of ganglioside GM3 in G2/M cell cycle arrest of human monocytic cells induced by Actinobacillus actinomycetemcomitans cytolethal distending toxin

Infection and Immunity

Volumn 73, Issue 8, 2005, Pages 4846-4852

  Mise, Koji ^a   Akifusa, Sumio ^a   Watarai, Shinobu ^b   Ansai, Toshihiro ^a   Nishihara, Tatsuji ^a   Takehara, Tadamichi ^a  

^a KYUSHU DENTAL COLLEGE   (Japan)

^b Osaka Prefecture University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 PHENYL 2 PALMITOYLAMINO 3 MORPHOLINO 1 PROPANOL; BACTERIAL TOXIN; CERAMIDE GLUCOSYLTRANSFERASE INHIBITOR; CYTOLETHAL DISTENDING TOXIN; CYTOLETHAL DISTENDING TOXIN RECEPTOR; GANGLIOSIDE GM1; GANGLIOSIDE GM2; GANGLIOSIDE GM3; GLUCOSYLCERAMIDE; GLYCOSPHINGOLIPID GB3; GLYCOSPHINGOLIPID GB4; PROTEIN CDTA; PROTEIN CDTB; PROTEIN CDTC; PROTEIN SUBUNIT; SPHINGOLIPID; UNCLASSIFIED DRUG;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE PHASE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; HOST CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METAPHASE; MITOSIS INHIBITION; MONOCYTE; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY; TOXIN ANALYSIS;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ACTINOBACILLUS INFECTIONS; BACTERIAL TOXINS; CELL CYCLE; CELL DIVISION; DNA; G(M3) GANGLIOSIDE; G2 PHASE; HUMANS; LIPOSOMES; MONOCYTES; SPHINGOLIPIDS; U937 CELLS;

EID: 23344447887     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.8.4846-4852.2005     Document Type: Article

References (48)

1. Akifusa, S., S. Poole, J. Lewthwaite, B. Henderson, and S. P. Nair. 2001. Recombinant Actinobacillus actinomycetemcomitans cytolethal distending toxin proteins are required to interact to inhibit human cell cycle progression and to stimulate human leukocyte cytokine synthesis. Infect. Immun. 69: 5925-5930.
2. Bock, K., M. E. Breimer, A. Brignole, G. C. Hansson, K. A. Karlsson, G. Larson, H. Leffler, B. E. Samuelsson, N. Stromberg, C. S. Eden, et al. 1985. Specificity of binding of a strain of uropathogenic Escherichia coli to Gal alpha 1-4Gal-containing glycosphingolipids. J. Biol. Chem. 260:8545-8551.
3. Cope, L. D., S. Lumbley, J. L. Latimer, J. Klesney-Tait, M. K. Stevens, L. S. Johnson, M. Purven, R. S. Munson, Jr., T. Lagergard, J. D. Radolf, and E. J. Hansen. 1997. A diffusible cytotoxin of Haemophilus ducreyi. Proc. Natl. Acad. Sci. USA 94:4056-4061.
4. Cortes-Bratti, X., E. Chaves-Olarte, T. Lagergard, and M. Thelestam. 2000. Cellular internalization of cytolethal distending toxin from Haemophilus ducreyi. Infect. Immun. 68:6903-6911.
5. Cortes-Bratti, X., C. Karlsson, T. Lagergard, M. Thelestam, and T. Frisan. 2001. The Haemophilus ducreyi cytolethal distending toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways. J. Biol. Chem. 276:5296-5302.
6. Deng, K., and E. J. Hansen. 2003. A CdtA-CdtC complex can block killing of HeLa cells by Haemophilus ducreyi cytolethal distending toxin. Infect. Immun. 71:6633-6640.
7. Fives-Taylor, P. M., D. H. Meyer, K. P. Mintz, and C. Brissette. 1999. Virulence factors of Actinobacillus actinomycelemcomitans. Periodontol. 2000; 20:136-167.
8. Fujinaga, Y., K. Inoue, S. Watarai, Y. Sakaguchi, H. Arimitsu, J. C. Lee, Y. Jin, T. Matsumura, Y. Kabumoto, T. Watanabe, T. Ohyama, A. Nishikawa, and K. Oguma. 2004. Molecular characterization of binding subcomponents of Clostridium botulinum type C progenitor toxin for intestinal epithelial cells and erythrocytes. Microbiology 150:1529-1538.
9. Hanada, K., T. Hara, M. Fukasawa, A. Yamaji, M. Umeda, and M. Nishijima. 1998. Mammalian cell mutants resistant to a sphingomyelin-directed cytolysin. Genetic and biochemical evidence for complex formation of the LCB1 protein with the LCB2 protein for serine palmitoyltransferase. J. Biol. Chem. 273:33787-33794.
10. Haraszthy, V. I., G. Hariharan, E. M. Tinoco, J. R. Cortelli, E. T. Lally, E. Davis, and J. J. Zambon. 2000. Evidence for the role of highly leukotoxic Actinobacillus actinomycetemcomitans in the pathogenesis of localized juvenile and other forms of early-onset periodontitis. J. Periodontol. 71:912-922.
11. Hassane, D. C., R. B. Lee, M. D. Mendenhall, and C. L. Pickett. 2001. Cytolethal distending toxin demonstrates genotoxic activity in a yeast model. Infect. Immun. 69:5752-5759.
12. Haubek, D., K. Poulsen, J. Westergaard, G. Dahlen, and M. Kilian. 1996. Highly toxic clone of Actinobacillus actinomycetemcomitans in geographically widespread cases of juvenile periodontitis in adolescents of African origin. J. Clin. Microbiol. 34:1576-1578.
13. Holmgren, J. 1981. Actions of cholera toxin and the prevention and treat-ment of cholera. Nature 292:413-417.
14. Inoue, K., Y. Fujinaga, K. Honke, K. Yokota, T. Ikeda, T. Ohyama, K. Takeshi, T. Watanabe, and K. Oguma. 1999. Characterization of haemagglutinin activity of Clostridium botulinum type C and D 16S toxins, and one subcomponent of haemagglutinin (HA1). Microbiology 145:2533-2542.
15. Kamin, S., W. Harvey, M. Wilson, and A. Scutt. 1986. Inhibition of fibroblast proliferation and collagen synthesis by capsular material from Actinobacillus actinomycelemcomitans. J. Med. Microbiol. 22:245-249.
16. Karlsson, K. A. 1989. Animal glycosphingolipids as membrane attachment sites for bacteria. Annu. Rev. Biochem. 58:309-350.
17. Kirby, A. C., S. Meghji, S. P. Nair, P. White, K. Reddi, T. Nishihara, K. Nakashima, A. C. Willis, R. Sim, M. Wilson, et al. 1995. The potent bone-resorbing mediator of Aclinobacillus actinomycelemcomitans is homologous to the molecular chaperone GroEL. J. Clin. Investig. 96:1185-1194.
18. Kovbasnjuk, O., M. Edidin, and M. Donowitz. 2001. Role of lipid rafts in Shiga toxin 1 interaction with the apical surface of Caco-2 cells. J. Cell Sci. 114:4025-4031.
19. Lara-Tejero, M., and J. E. Galan. 2000. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 290:354-357.
20. Lara-Tejero, M., and J. E. Galan. 2001. CdtA, CdtB, and CdtC form a tripartite complex that is required for cytolethal distending toxin activity. Infect. Immun. 69:4358-4365.
21. Lara-Tejero, M., and J. E. Galan. 2002. Cytolethal distending toxin: limited damage as a strategy to modulate cellular functions. Trends Microbiol. 10:147-152.
22. Lee, R. B., D. C. Hassane, D. L. Cottle, and C. L. Pickett. 2003. Interactions of Campylobacter jejuni cytolethal distending toxin subunits CdtA and CdtC with HeLa cells. Infect. Immun. 71:4883-4890.
23. Mao, X., and J. M. DiRienzo. 2002. Functional studies of the recombinant subunits of a cytolethal distending holotoxin. Cell. Microbiol. 4:245-255.
24. Meyer, D. H., and P. M. Fives-Taylor. 1997. The role of Actinobacillus actinomycelemcomitans in the pathogenesis of periodontal disease. Trends Microbiol. 5:224-228.
25. Misasi, R., M. Sorice, T. Garofalo, T. Griggi, W. M. Campana, M. Giammatteo, A. Pavan, M. Hiraiwa, G. M. Pontieri, and J. S. O'Brien. 1998. Colocalization and complex formation between prosaposin and monosialoganglioside GM3 in neural cells. J. Neurochem. 71:2313-2321.
26. Nesic, D., Y. Hsu, and C. E. Stebbins. 2004. Assembly and function of a bacterial genotoxin. Nature 429:429-433.
27. 2/M phase and apoptosis. Infect. Immun. 66:5980-5987.
28. Okuda, J., M. Fukumoto, Y. Takeda, and M. Nishibuchi. 1997. Examination of diarrheagenicity of cytolethal distending toxin: suckling mouse response to the products of the cdtABC genes of Shigella dysenteriae. Infect. Immun. 65:428-433.
29. Peres, S. Y., O. Marches, F. Daigle, J. P. Nougayrede, F. Herault, C. Tasca, J. De Rycke, and E. Oswald. 1997. A new cytolethal distending toxin (CDT) from Escherichia cou producing CNF2 blocks HeLa cell division in G2/M phase. Mol. Microbiol. 24:1095-1107.
30. Pickett, C. L., D. L. Cottle, E. C. Pesci, and G. Bikah. 1994. Cloning, sequencing, and expression of the Escherichia coli cytolethal distending toxin genes. Infect. Immun. 62:1046-1051.
31. Pickett, C. L., E. C. Pesci, D. L. Cottle, G. Russell, A. N. Erdem, and H. Zeytin. 1996. Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter sp. cdtB genes. Infect. Immun. 64:2070-2078.
32. Pickett, C. L., and C. A. Whitehouse. 1999. The cytolethal distending toxin family. Trends Microbiol. 7:292-297.
33. Rodenburg, J. P., A. J. van Winkelhoff, E. G. Winkel, R. J. Goene, F. Abbas, and J. de Graff. 1990. Occurrence of Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in severe periodontitis in relation to age and treatment history. J. Clin. Periodontol. 17:392-399.
34. Shenker, B. J. 1987. Immunologic dysfunction in the pathogenesis of periodontal diseases. J. Clin. Periodontol. 14:489-498.
35. Slots, J., and M. Ting. 1999. Actinobacillus actinomycetemcomitans and Porphyromonas gingivatis in human periodontal disease: occurrence and treatment. Periodontol. 2000;20:82-121.
36. Suda, T., I. Nakamura, E. Jimi, and N. Takahashi. 1997. Regulation of osteoclast function. J. Bone Miner. Res. 12:869-879.
37. Sugai, M., T. Kawamoto, S. Y. Peres, Y. Ueno, H. Komatsuzawa, T. Fujiwara, H. Kurihara, H. Suginaka, and E. Oswald. 1998. The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect. Immun. 66:5008-5019.
38. Sullivan, P, W. L. Clark, and P. K. Kaiser. 2002. Bilateral endogenous endophthalmitis caused by HACEK microorganism. Am. J. Ophthalmol. 133:144-145.
39. Tetaud, C., T. Falguieres, K. Carlier, Y. Lecluse, J. Garibal, D. Coulaud, P. Busson, R. Steffensen, H. Clausen, L. Johannes, and J. Wiels. 2003. Two distinct Gb3/CD77 signaling pathways leading to apoptosis are triggered by anti-Gb3/CD77 mAb and verotoxin-1. J. Biol. Chem. 278:45200-45208.
40. van Winkelhoff, A. J., and J. Slots. 1999. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in nonoral infections. Periodontol. 2000 20:122-135.
41. Watarai, S., S. Handa, T. Tadakuma, and T. Yasuda. 1987. Application of liposomes to generation of monoclonal antibody to glycosphingolipid: production of monoclonal antibody to GgOse4Cer. J. Biochem. (Tokyo) 102: 59-67.
42. Watarai, S., Tana, K. Inoue, Y. Kushi, E. Isogai, K. Yokota, K. Naka, K. Oguma, and H. Kodama. 2001. Inhibition of Vero cell cytotoxic activity in Escherichia coli O157:H7 lysates by globotriaosylceramide, Gb3, from bovine milk. Biosci. Biotechnol. Biochem. 65:414-419.
43. White, P. A., M. Patel, S. Nair, J. Ashmore, P. Galgut, M. Wilson, B. Henderson, and I. Olsen. 1998. Control of the human cell cycle by a bacterial protein, gapstatin. Eur. J. Cell Biol. 77:228-238.
44. White, P. A., M. Wilson, S. P. Nair, A. C. Kirby, K. Reddi, and B. Henderson. 1995. Characterization of an antiproliferative surface-associated protein from Actinobacillus actinomycelemcomitans which can be neutralized by sera from a proportion of patients with localized juvenile periodontitis. Infect. Immun. 63:2612-2618.
45. 2-phase cell cycle block. Infect. Immun. 66:1934-1940.
46. Wilson, M., and B. Henderson. 1995. Virulence factors of Actinobacillus actinomycetemcomitans relevant to the pathogenesis of inflammatory periodontal diseases. FEMS Microbiol. Rev. 17:365-379.
47. Young, V. B., K. A. Knox, and D. B. Schauer. 2000. Cytolethal distending toxin sequence and activity in the enterohepatic pathogen Helicobacter hepaticus. Infect. Immun. 68:184-191.
48. Zambon, J. J. 1985. Actinobacillus actinomycetemcomitans in human periodontal disease. J. Clin. Periodontol. 12:1-20.